The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease
Alexis Thomas1, Ardeshir Bayat1,21Plastic and Reconstructive Surgery Research, School of Translational Medicine, University of Manchester, Manchester Interdisciplinary Biocentre, Manchester, UK; 2Department of Plastic and Reconstructive Surgery, Manchester Academic Health Science Centre, University...
Saved in:
Main Authors: | Alexis Thomas (Author), Ardeshir Bayat (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2010-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis
by: Zah V, et al.
Published: (2020) -
Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis [Corrigendum]
by: Zah V, et al.
Published: (2021) -
Optimization of Col H Gene Encoding Clostridium histolyticum Collagenase to Express in Escherichia coli
by: Seyed Mohammad Amin Mahdian, et al.
Published: (2022) -
The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie's disease: A meta-analysis of published prospective studies
by: Fuxun Zhang, et al.
Published: (2022) -
Clostridium histolyticum (AA4500) for the Treatment of Adhesive Capsulitis of the Shoulder: A Randomised Double-Blind, Placebo-Controlled Study for the Safety and Efficacy of Collagenase – Single Site Report
by: Fitzpatrick J, et al.
Published: (2020)